SE392721B - Forfarande for framstellning av peptider med psykofarmakologiska egenskaper - Google Patents
Forfarande for framstellning av peptider med psykofarmakologiska egenskaperInfo
- Publication number
- SE392721B SE392721B SE7309861A SE7309861A SE392721B SE 392721 B SE392721 B SE 392721B SE 7309861 A SE7309861 A SE 7309861A SE 7309861 A SE7309861 A SE 7309861A SE 392721 B SE392721 B SE 392721B
- Authority
- SE
- Sweden
- Prior art keywords
- procedure
- preparing peptides
- psychopharmacological properties
- psychopharmacological
- properties
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 230000001003 psychopharmacologic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/695—Corticotropin [ACTH]
- C07K14/6955—Corticotropin [ACTH] with at least 1 amino acid in D-form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NLAANVRAGE7209839,A NL175618C (nl) | 1972-07-15 | 1972-07-15 | Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat bevat, alsmede een werkwijze ter bereiding van dergelijke peptiden. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE392721B true SE392721B (sv) | 1977-04-18 |
Family
ID=19816526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7309861A SE392721B (sv) | 1972-07-15 | 1973-07-13 | Forfarande for framstellning av peptider med psykofarmakologiska egenskaper |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US3853838A (xx) |
| JP (1) | JPS5936611B2 (xx) |
| AU (1) | AU471401B2 (xx) |
| BE (1) | BE802335A (xx) |
| CA (1) | CA1019723A (xx) |
| CH (1) | CH605674A5 (xx) |
| DE (1) | DE2335826C2 (xx) |
| FR (1) | FR2192838B1 (xx) |
| GB (1) | GB1439225A (xx) |
| HU (1) | HU169437B (xx) |
| NL (1) | NL175618C (xx) |
| SE (1) | SE392721B (xx) |
| ZA (1) | ZA734648B (xx) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7607683A (nl) * | 1976-07-12 | 1978-01-16 | Akzo Nv | Werkwijze ter bereiding van nieuwe peptiden en peptide-derivaten en de toepassing hiervan. |
| US4144228A (en) * | 1976-05-07 | 1979-03-13 | G. D. Searle & Co. | Methionine5 -enkephalin sulfoxides and sulfones |
| NL7607684A (nl) * | 1976-07-12 | 1978-01-16 | Akzo Nv | Werkwijze ter bereiding van nieuwe peptiden en peptide-derivaten en de toepassing hiervan. |
| US4356119A (en) * | 1978-09-28 | 1982-10-26 | Nordisk Insulinlaboratorium | Therapeutically active polypeptides or acid addition salts and a process for producing such compounds |
| US4623715A (en) * | 1984-10-22 | 1986-11-18 | Hoechst Aktiengeselleschaft | Novel peptides which are active on the central nervous system and have an action on the cholinergic system |
| NZ214543A (en) * | 1984-12-14 | 1990-03-27 | Australian Commercial Research | Amino acid and peptide derivatives that inhibit human leucocytic elastase enzyme (hle) |
| US7592304B2 (en) | 1999-10-01 | 2009-09-22 | Dmi Life Sciences, Inc. | Metal-binding compounds and uses therefor |
| US7632803B2 (en) * | 1999-10-01 | 2009-12-15 | Dmi Life Sciences, Inc. | Metal-binding compounds and uses therefor |
| EP2560486B1 (en) | 2010-04-21 | 2018-11-21 | Signature Therapeutics, Inc. | Compositions comprising enzyme-cleavable amphetamine prodrugs and inhibitors thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL278010A (xx) * | 1961-05-04 | 1900-01-01 | ||
| NL6509727A (xx) * | 1965-07-28 | 1967-01-30 | ||
| GB1230472A (xx) * | 1967-07-10 | 1971-05-05 |
-
1972
- 1972-07-15 NL NLAANVRAGE7209839,A patent/NL175618C/xx not_active IP Right Cessation
-
1973
- 1973-07-05 GB GB3213473A patent/GB1439225A/en not_active Expired
- 1973-07-10 ZA ZA734648A patent/ZA734648B/xx unknown
- 1973-07-10 US US00377978A patent/US3853838A/en not_active Expired - Lifetime
- 1973-07-11 CA CA176,197A patent/CA1019723A/en not_active Expired
- 1973-07-11 AU AU57983/73A patent/AU471401B2/en not_active Expired
- 1973-07-13 BE BE133475A patent/BE802335A/xx not_active IP Right Cessation
- 1973-07-13 SE SE7309861A patent/SE392721B/xx unknown
- 1973-07-13 CH CH1025473A patent/CH605674A5/xx not_active IP Right Cessation
- 1973-07-13 DE DE2335826A patent/DE2335826C2/de not_active Expired
- 1973-07-13 FR FR7325905A patent/FR2192838B1/fr not_active Expired
- 1973-07-13 JP JP48079221A patent/JPS5936611B2/ja not_active Expired
- 1973-07-13 HU HUAO372A patent/HU169437B/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL7209839A (xx) | 1974-01-17 |
| FR2192838A1 (xx) | 1974-02-15 |
| AU471401B2 (en) | 1976-04-29 |
| FR2192838B1 (xx) | 1977-01-28 |
| BE802335A (fr) | 1974-01-14 |
| JPS5936611B2 (ja) | 1984-09-05 |
| CA1019723A (en) | 1977-10-25 |
| US3853838A (en) | 1974-12-10 |
| DE2335826C2 (de) | 1984-01-05 |
| CH605674A5 (xx) | 1978-10-13 |
| DE2335826A1 (de) | 1974-01-31 |
| NL175618B (nl) | 1984-07-02 |
| NL175618C (nl) | 1984-12-03 |
| GB1439225A (en) | 1976-06-16 |
| HU169437B (xx) | 1976-11-28 |
| JPS4951278A (xx) | 1974-05-18 |
| AU5798373A (en) | 1975-01-16 |
| ZA734648B (en) | 1974-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE400771B (sv) | Forfarande for framstellning av 3alfa-hydroxi- och 3alfa-hydroxi-19-norpregnaner | |
| SE415261B (sv) | Forfarande for framstellning av berarbundna polypeptider | |
| SE413246B (sv) | Forfarande for framstellning av kolesteroloxidas | |
| NO141568C (no) | Fremgangsmaate for fremstilling av cellulosemasse med hoey lyshet | |
| NO140731C (no) | Fremgangsmaate for fremstilling av dimetyleter | |
| SE392613B (sv) | Forfarande for framstellning av peptider med psykofarmakologiska egenskaper | |
| SE419339B (sv) | Forfarande for framstellning av substituerade sulfonylacetamidocefalosporiner | |
| NO140828C (no) | Fremgangsmaate for fremstilling av pullulan | |
| SE397530B (sv) | Forfarande for framstellning av 1-pyrazolylalkyl-4-arylpiperazinderivat | |
| NO139124C (no) | Fremgangsmaate for fremstilling av estere | |
| SE382550B (sv) | Forfarande for framstellning av livsmedel innehallande pullulan | |
| IT1002557B (it) | Procedimento per preparare dimetil naftaline | |
| SE392721B (sv) | Forfarande for framstellning av peptider med psykofarmakologiska egenskaper | |
| SE423092B (sv) | Forfarande for framstellning av vissa 13-tiaprostaglandiner | |
| SE7611202L (sv) | Forfarande for framstellning av pyrazolodiazepinforeningar | |
| NO139130C (no) | Fremgangsmaate til fremstilling av 2-alkylamino-dihydropyridiner | |
| SE415146B (sv) | Forfarande for framstellning av forbettrad epoxideringskatalysator | |
| SE387344B (sv) | Forfarande for framstellning av pyrazin-4-oxidderivat | |
| SE410603B (sv) | Forfarande for framstellning av d-2,6-dimetyl-8-cyano- eller 8-karboxamido-metylergolin | |
| SE380272B (sv) | Forfarande for framstellning av n-fosfonmetylglycin | |
| IT999554B (it) | Procedimento per preparare diacetossibutano | |
| SE386664B (sv) | Forfarande for framstellning av cystinhaltiga peptider | |
| RO69492A2 (ro) | Procedeu pentru prepararea perclor-metil-mercaptanului | |
| FI56830B (fi) | Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider | |
| SE402454B (sv) | Forfarande for framstellning av 2-alkoxi-5-alkylsulfonyl-toluen |